Working Papers, Research Center on Health and Economics
From Department of Economics and Business, Universitat Pompeu Fabra
Bibliographic data for series maintained by ( this e-mail address is bad, please contact ).
Access Statistics for this working paper series.
Is something missing from the series or not right? See the RePEc data check for the archive and series.
- 1219: Putting health in all policies: The National Institute for Welfare Enhancement

- Vicente Ortun and Beatriz González López-Valcárcel
- 1139: Hybrid risk adjustment for pharmaceutical benefits

- Manuel García-Goñi, Pere Ibern and José María Inoriza
- 1138: Estimates of patient costs related with population morbidity: Can indirect costs affect the results?

- M. Carreras, Manuel García-Goñi, Pere Ibern, J. Coderch, L. Vall-Llosera and José María Inoriza
- 1023: Informal care and labour force participation among middle-aged women in Spain

- David Casado, Pilar Garcia-Gomez and Ángel López
- 1014: Generic entry into a regulated pharmaceutical market

- Iván Moreno Torres, Jaume Puig and Joan-Ramon Borrell
- 993: Health care management autonomy: Evidence from the Catalonian hospital sector in a decentralised Spain

- Guillem López Casasnovas, David McDaid and Joan Costa-Font
- 984: Organisational innovations and health care decentralisation: A perspective from Spain

- Guillem López Casasnovas
- 983: Social spending and demographics: The role of public policies in the intergenerational redistribution of income. Empirical evidence from Spain and Catalonia

- Guillem López Casasnovas and Ana Mosterin
- 978: The impact of Economics on health policy and management in Spain

- Vicente Ortun and Ricard Meneu de Guillerna
- 977: Predictability of drug expenditures: An application using morbidity data

- Manuel García-Goñi and Pere Ibern
- 929: Allowing for heterogeneity in the decomposition of measures of inequality in health

- Andrew Jones and Ángel López
- 906: The impact of generic reference pricing interventions in the statin market

- Jaume Puig
- 810: La evaluación del gasto sanitario en España en sus niveles y determinantes

- Guillem López Casasnovas
- 797: Responsabilidad social corporativa. Una visión desde la teoría económica

- Aleix Calveras and Juan-José Ganuza
- 762: Regulatory ambivalence and the limitations of pharmaceutical policy in Spain

- Joan Costa and Jaume Puig
- 758: Socio-economic inequalities in health in Catalonia

- Pilar Garcia-Gomez and Ángel López
- 757: Regional differences in socio-economic health inequalities in Spain

- Pilar Garcia-Gomez and Ángel López
- 756: The evolution of inequity in the access to health care in Spain: 1987-2001

- Pilar Garcia-Gomez and Ángel López
- 754: Patentes, regulación de precios e innovación en la industria farmacéutica

- Vicente Ortun
- 752: El impacto de los servicios sanitarios sobre la salud

- Vicente Ortun, Ricard Meneu and Salvador Peiró
- 747: La gestión sanitaria: orientaciones a futuro para el cambio organizativo, del control y la financiación

- Guillem López Casasnovas
- 746: The effects of poor financial information systems on the long term sustainability of local public services. Empirical evidence from the Catalan Municipalities

- Eugeni Garcia Alegre and Guillem López Casasnovas
- 745: Diversity and regional inequalities: Assessing the outcomes of the Spanish 'System of Health Care Services'

- Guillem López Casasnovas, Joan Costa-Font and Ivan Planas
- 719: Cost efficiency in primary care contracting: A stochastic frontier cost function approach

- Jaume Puig and Vicente Ortun
- 711: Measurement and explanation of socioeconomic inequality in health with longitudinal data

- Andrew Jones and Ángel López
- 705: Eliciting consumers preferences using stated preference discrete choice models: Contingent ranking versus choice experiment

- Anna Merino
- 704: Demand for pharmaceutical drugs: A choice modelling experiment

- Anna Merino
- 679: Incentives and pharmaceutical reimbursement reforms in Spain

- Jaume Puig
- 676: A consistency test of the time trade-off

- Han Bleichrodt, José Luis Pinto and Jose-Maria Abellan-Perpiñan
- 662: Pharmaceutical generics, vertical product differentiation and public policy

- Antonio Cabrales
- 632: Are tax subsidies for private medical insurance self-financing? Evidence from a microsimulation model for outpatient and inpatient episodes

- Ángel López-Nicolás and Marcos Vera-Hernandez
- 626: The importance of individual heterogeneity in the decomposition of measures of socioeconomic inequality in health: An approach based on quantile regression

- Andrew Jones and Ángel López-Nicolás
- 609: La imposición de los carburantes de automoción en España: algunas observaciones teóricas y empíricas

- Xavier Labandeira Villot and Ángel López Nicolás
- 572: A multilevel analysis on the determinants of regional health care expenditure. A note

- Guillem López Casasnovas and Marc Sáez
- 551: Testing the descriptive performance of the rank-dependent utility in the domain of health profiles

- Jose-Maria Abellan-Perpiñan and José Luis Pinto
- 550: ¿Es posible reducir el gasto sanitario a través del subsidio a los seguros sanitarios privados? La doble cobertura sanitaria en Catalunya. Estimación de patrones de utilización de servicios sanitarios y simulación de costes asociados a la asistencia

- Ángel López Nicolás, Jaume Garcia Villar, Guillem López Casasnovas and Jaume Puig
- 548: How important are tobacco prices in the propensity to start and quit smoking? An analysis of smoking histories from the Spanish National Health Survey

- Ángel López Nicolás
- 531: Demand for private health insurance: Is there a quality gap?

- Joan Costa-Font and Jaume Garcia Villar
- 524: The impact of the reference price system on the pharmaceutical market: A theoretical approach

- Anna Merino
- 523: Financiación capitativa, articulación entre niveles asistenciales y descentralización de las organizaciones sanitarias

- Vicente Ortun and Guillem López Casasnovas
- 519: Financement et autonomie fiscale de la Catalogne: Deux décénnies de problèmes non résolus

- Guillem López Casasnovas
- 479: Equity considerations in health care: An axiomatic bargaining approach

- Xavier Cuadras-Morató, José Luis Pinto and Jose-Maria Abellan-Perpiñan
- 473: The social value of health programs: Is age a relevant factor?

- Eva Rodríguez Míguez and José Luis Pinto
- 472: The significance of distributive effects in social assessment of health care

- Eva Rodríguez Míguez and José Luis Pinto
- 467: An experimental test of loss aversion and scale compatibility

- Han Bleichrodt and José Luis Pinto
- 439: Radial measures of public services deficit for regional allocation of public funds

- Jaume Puig
- 399: La capitación en la financiación territorial de los servicios públicos transferidos: el caso de la sanidad y de la educación

- Guillem López Casasnovas
- 362: Review of the literature on reference pricing

- Guillem López Casasnovas and Jaume Puig
- 308: Health care provider choice in the case of patient-initiated contacts. An extended version of discrete choice of model demand

- Jaume Puig, Marc Sáez and Esther Martinez-Garcia
- 307: Las deducciones en el IRPF por gasto sanitario privado: situación actual y posibilidades de reforma

- Esther Martinez-Garcia
- 278: Cost-containment in health care: The case of Spain from the eighties up to 1997

- Guillem López Casasnovas
- 265: Finance versus costs for teaching hospitals in Spain

- Guillem López Casasnovas and Marc Sáez
- 240: Unobserved heterogeneity and censoring in the demand for health care

- Ángel López Nicolás
- 220: On optimal location with treshold requirements

- Miquel Carreras and Daniel Serra
- 218: Una modelización de los años de vida ajustados por la calidad como utilidades esperadas

- Jose-Maria Abellan-Perpiñan and José L. Pinto
- 214: Market structure and hospital efficiency: Evaluating potential effects of deregulation in a national health service

- Eulàlia Dalmau and Jaume Puig